Targeting	B:C1159372
the	O
Nrf2	O
/	O
Amyloid	O
-	I:C1149161
Beta	I:C1149161
Liaison	I:C1149161
in	O
Alzheimer	O
's	I:C0002395
Disease	I:C0002395
:	O
A	O
Rational	O
Approach	O
.	O

Targeting	O
the	O
Nrf2	B:C0289507
/	O
Amyloid	O
-	I:C1149161
Beta	I:C1149161
Liaison	I:C1149161
in	O
Alzheimer	O
's	I:C0002395
Disease	I:C0002395
:	O
A	O
Rational	O
Approach	O
.	O

Targeting	O
the	O
Nrf2	O
/	O
Amyloid	B:C1149161
-	I:C1149161
Beta	I:C1149161
Liaison	I:C1149161
in	O
Alzheimer	O
's	I:C0002395
Disease	I:C0002395
:	O
A	O
Rational	O
Approach	O
.	O

Targeting	O
the	O
Nrf2	O
/	O
Amyloid	O
-	I:C1149161
Beta	I:C1149161
Liaison	I:C1149161
in	O
Alzheimer	B:C0002395
's	I:C0002395
Disease	I:C0002395
:	O
A	O
Rational	O
Approach	O
.	O

Amyloid	B:C0002716
is	O
a	O
prominent	O
feature	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
.	O

Amyloid	O
is	O
a	O
prominent	O
feature	O
of	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
.	O

Amyloid	O
is	O
a	O
prominent	O
feature	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
)	O
.	O

Yet	O
,	O
a	O
linear	B:C0205132
linkage	O
between	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
(	O
amyloid	O
-	I:C0078939
β	I:C0078939
peptide	I:C0078939
)	O
and	O
the	O
disease	O
onset	O
and	O
progression	O
has	O
recently	O
been	O
questioned	O
.	O

Yet	O
,	O
a	O
linear	O
linkage	O
between	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
(	O
amyloid	O
-	I:C0078939
β	I:C0078939
peptide	I:C0078939
)	O
and	O
the	O
disease	O
onset	O
and	O
progression	O
has	O
recently	O
been	O
questioned	O
.	O

Yet	O
,	O
a	O
linear	O
linkage	O
between	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
(	O
amyloid	B:C0078939
-	I:C0078939
β	I:C0078939
peptide	I:C0078939
)	O
and	O
the	O
disease	O
onset	O
and	O
progression	O
has	O
recently	O
been	O
questioned	O
.	O

Yet	O
,	O
a	O
linear	O
linkage	O
between	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
(	O
amyloid	O
-	I:C0078939
β	I:C0078939
peptide	I:C0078939
)	O
and	O
the	O
disease	O
onset	O
and	O
progression	B:C0242656
has	O
recently	O
been	O
questioned	O
.	O

In	O
this	O
context	O
,	O
the	O
crucial	O
partnership	O
between	O
amyloid	B:C1510880
-β	I:C1510880
peptide	I:C1510880
and	O
Nrf2	O
pathways	I:C1518762
is	O
acquiring	O
paramount	O
importance	O
,	O
offering	O
prospects	O
for	O
deciphering	O
the	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
-	O
centered	O
disease	O
network	O
.	O

In	O
this	O
context	O
,	O
the	O
crucial	O
partnership	O
between	O
amyloid	O
-β	I:C1510880
peptide	I:C1510880
and	O
Nrf2	B:C1518762
pathways	I:C1518762
is	O
acquiring	O
paramount	O
importance	O
,	O
offering	O
prospects	O
for	O
deciphering	O
the	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
-	O
centered	O
disease	O
network	O
.	O

In	O
this	O
context	O
,	O
the	O
crucial	O
partnership	O
between	O
amyloid	O
-β	I:C1510880
peptide	I:C1510880
and	O
Nrf2	O
pathways	I:C1518762
is	O
acquiring	O
paramount	O
importance	O
,	O
offering	O
prospects	O
for	O
deciphering	O
the	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
-	O
centered	O
disease	O
network	O
.	O

In	O
this	O
context	O
,	O
the	O
crucial	O
partnership	O
between	O
amyloid	O
-β	I:C1510880
peptide	I:C1510880
and	O
Nrf2	O
pathways	I:C1518762
is	O
acquiring	O
paramount	O
importance	O
,	O
offering	O
prospects	O
for	O
deciphering	O
the	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
-	O
centered	O
disease	B:C0012634
network	O
.	O

Here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
antiaggregating	B:C0085826
agents	I:C0085826
rationally	O
designed	O
to	O
simultaneously	O
activate	O
transcription	I:C0162493
-	O
based	O
antioxidant	O
responses	O
,	O
whose	O
lead	O
1	I:C1254351
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O

Here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
antiaggregating	O
agents	I:C0085826
rationally	O
designed	O
to	O
simultaneously	O
activate	B:C0162493
transcription	I:C0162493
-	O
based	O
antioxidant	O
responses	O
,	O
whose	O
lead	O
1	I:C1254351
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O

Here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
antiaggregating	O
agents	I:C0085826
rationally	O
designed	O
to	O
simultaneously	O
activate	O
transcription	I:C0162493
-	O
based	O
antioxidant	B:C0003402
responses	O
,	O
whose	O
lead	O
1	I:C1254351
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O

Here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
antiaggregating	O
agents	I:C0085826
rationally	O
designed	O
to	O
simultaneously	O
activate	O
transcription	I:C0162493
-	O
based	O
antioxidant	O
responses	B:C0683154
,	O
whose	O
lead	O
1	I:C1254351
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O

Here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
antiaggregating	O
agents	I:C0085826
rationally	O
designed	O
to	O
simultaneously	O
activate	O
transcription	I:C0162493
-	O
based	O
antioxidant	O
responses	O
,	O
whose	O
lead	B:C1254351
1	I:C1254351
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O

Relying	O
on	O
the	O
requirements	B:C0556043
of	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
recognition	O
,	O
we	O
identified	O
the	O
catechol	O
derivative	I:C1254351
12	I:C1254351
.	O

Relying	O
on	O
the	O
requirements	O
of	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
recognition	O
,	O
we	O
identified	O
the	O
catechol	O
derivative	I:C1254351
12	I:C1254351
.	O

Relying	O
on	O
the	O
requirements	O
of	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
recognition	O
,	O
we	O
identified	O
the	O
catechol	B:C1254351
derivative	I:C1254351
12	I:C1254351
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	B:C1254351
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	B:C0079381
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	B:C1518762
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	B:C0017391
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	B:C0289507
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	B:C2164680
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	B:C0919428
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	O
response	I:C0040649
.	O

In	O
SH	O
-	O
SY5Y	O
neuroblastoma	O
cells	O
,	O
12	O
combined	O
remarkable	O
free	O
radical	I:C0079381
scavenger	I:C0079381
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
Nrf2	O
pathway	I:C1518762
and	O
induce	O
the	O
Nrf2	O
-	O
dependent	O
defensive	O
gene	O
NQO1	I:C0919428
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	B:C0040649
response	I:C0040649
.	O

Moreover	O
,	O
12	O
prevented	O
the	O
formation	O
of	O
cytotoxic	O
stable	O
oligomeric	B:C1254351
intermediates	I:C1254351
,	O
being	O
significantly	O
more	O
effective	O
,	O
and	O
per	O
se	O
less	O
toxic	I:C0013221
,	O
than	O
prototype	O
1	I:C1254351
.	O

Moreover	O
,	O
12	O
prevented	O
the	O
formation	O
of	O
cytotoxic	O
stable	O
oligomeric	O
intermediates	I:C1254351
,	O
being	O
significantly	O
more	O
effective	O
,	O
and	O
per	O
se	O
less	B:C0013221
toxic	I:C0013221
,	O
than	O
prototype	O
1	I:C1254351
.	O

Moreover	O
,	O
12	O
prevented	O
the	O
formation	O
of	O
cytotoxic	O
stable	O
oligomeric	O
intermediates	I:C1254351
,	O
being	O
significantly	O
more	O
effective	O
,	O
and	O
per	O
se	O
less	O
toxic	I:C0013221
,	O
than	O
prototype	B:C1254351
1	I:C1254351
.	O

More	O
importantly	O
,	O
as	O
different	O
chemical	O
features	O
were	O
exploited	O
to	O
regulate	B:C1523114
Nrf2	I:C1523114
and	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
activities	O
,	O
the	O
two	O
pathways	O
could	O
be	O
tuned	O
independently	O
.	O

More	O
importantly	O
,	O
as	O
different	O
chemical	O
features	O
were	O
exploited	O
to	O
regulate	O
Nrf2	I:C1523114
and	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
activities	O
,	O
the	O
two	O
pathways	O
could	O
be	O
tuned	O
independently	O
.	O

More	O
importantly	O
,	O
as	O
different	O
chemical	O
features	O
were	O
exploited	O
to	O
regulate	O
Nrf2	I:C1523114
and	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
activities	B:C1148560
,	O
the	O
two	O
pathways	O
could	O
be	O
tuned	O
independently	O
.	O

More	O
importantly	O
,	O
as	O
different	O
chemical	O
features	O
were	O
exploited	O
to	O
regulate	O
Nrf2	I:C1523114
and	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
activities	O
,	O
the	O
two	O
pathways	B:C1704259
could	O
be	O
tuned	O
independently	O
.	O

These	O
findings	O
point	O
to	O
compound	B:C1254351
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	B:C1254351
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	B:C0289507
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	B:C0078939
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	B:C0007634
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	B:C1254351
leads	I:C1254351
to	O
confront	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

These	O
findings	O
point	O
to	O
compound	O
12	I:C1254351
and	O
its	O
derivatives	O
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
Nrf2	O
/	O
amyloid	O
-β	I:C0078939
peptide	I:C0078939
cellular	O
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	O
leads	I:C1254351
to	O
confront	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
.	O

